VentriPoint Diagnostics Ltd.

VentriPoint Diagnostics Ltd.

VPTDF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.52M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
VentriPoint Diagnostics Ltd.VentriPoint Diagnostics Ltd.-5-60%--0.7
$-0.04

Current Fair Value

186% downside

Overvalued by 186% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$8.52 Million
Enterprise Value$10.80 Million
Earnings per Share$-0.02
Beta0.04
Outstanding Shares186,765,654

Return

Return on Equity60.47%ROE
Return on Assets-378.80%
Return on Invested Capital45.75%

Valuation & Multiples

P/E Ratio-4.98P/E Ratio
PEG10.59PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.05Price to Book Ratio
Enterprise Value to Revenue73.08
Enterprise Value to EBIT-6.26
Enterprise Value to Net Income-5
Total Debt to Enterprise0.24
Debt to Equity-0.68Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 1, 2026
EPS
-$0.00
Reported
Revenue
$13,781
Reported

Next Earnings Call

Expected Date
November 26, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About VentriPoint Diagnostics Ltd.

3 employees
CEO: Hugh MacNaught

VentriPoint Diagnostics Ltd. (VPTDF) is a medical technology company dedicated to creating and bringing to market diagnostic tools for the global assessment of patients with cardiac conditions. The company's primary offering is the Ventr...